EMEA-002115-PIP01-17-M05
Key facts
Invented name |
Dovprela (previously Pretomanid FGK)
|
Active substance |
Pretomanid
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0292/2022
|
PIP number |
EMEA-002115-PIP01-17-M05
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of multi-drug-resistant tuberculosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Global Alliance for TB Drug Development
Tel. +1 2122277450 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|